Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0
Open Access
- 29 January 2023
- journal article
- editorial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2542
Abstract
Breast cancer (BC) is the most common malignancy in women worldwideKeywords
This publication has 13 references indexed in Scilit:
- Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast CancerInternational Journal of Molecular Sciences, 2022
- Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer LineInternational Journal of Molecular Sciences, 2022
- The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?International Journal of Molecular Sciences, 2021
- Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectorsJournal of Experimental & Clinical Cancer Research, 2021
- Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to PaclitaxelInternational Journal of Molecular Sciences, 2021
- Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer CellsInternational Journal of Molecular Sciences, 2021
- MAT2A Localization and Its Independently Prognostic Relevance in Breast Cancer PatientsInternational Journal of Molecular Sciences, 2021
- Breast cancerThe Lancet, 2021
- RETRACTED: A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell PlasticityInternational Journal of Molecular Sciences, 2020
- Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast CanceriScience, 2020